Company Overview and News
The U.S. Energy Department's weekly inventory release showed a larger-than-expected increase in natural gas supplies. Despite the headline miss, the report pointed to a tightening market dynamic and boosted the fuel’s price, which added around 1.5% for the week.
Carl Icahn is joining his protege, Keith Meister, in a deal that may ultimately lead to their purchase of oil and gas producer Energen Corp.
On May 11–18, upstream stock Chesapeake Energy (CHK) was the top gainer on our list of energy stocks. During this period, the SPDR S&P Oil & Gas Exploration & Production ETF (XOP) rose 4.6%—the largest gainer among the major energy subsector ETFs that we discussed in the previous part of this series.
U.S. stock futures are surging higher this morning. Wall Street bulls are taking charge again after the U.S. and China called a trade truce that could lower America’s Chinese trade deficit.
This appears to be a rally for disciplined (expert) traders rather than buy and hold investors.
This week, crude oil (USO) prices increased ~2.6% from last week’s close of $70.70 per barrel to $71.49 per barrel by Thursday. Unleaded gasoline (UGA) and heating oil prices are up ~2.5% and ~2.7% so far this week.
For the week starting on May 14, crude oil (USO) prices increased ~1.1% or from last week’s close of $70.70 per barrel to $71.49 per barrel by Wednesday. Unleaded gasoline (UGA) and heating oil prices have risen ~2.8% and ~2.1% this week.
In this part, we’ll discuss the top percentage gainers from the upstream sector in the US for the week starting on May 14. To compile the list of the top upstream gainers, we only used oil and gas producers with market capitalizations greater than $100 million and an average trading volume greater than 100,000 shares last week.
West Texas Intermediate (WTI) crude continues to trade above the $70-a-barrel psychological mark in the wake of concerns that Iran’s crude export might fall after Trump nixed the nuclear deal.
Chesapeake has seen shares move higher following solid first quarter results and a jump in oil prices.
Chesapeake Energy Corporation (CHK - Free Report) was a big mover last session, as the company saw its shares rise more than 9% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This continues the recent uptrend for the company—as the stock is now up 41.6% in the past one-month time frame. The company has seen a mixed track record when it comes to estimate revisions of one increase and six decreases over the past month, while the Zacks Consensus Estimate moved lower in the said time period.
On May 17, natural gas’s implied volatility was 20.6%, 0.5% higher than its 15-day moving average.
Chesapeake Energy (CHK) stock increased 18.5% in the week ending May 15. The stock was supported by higher crude oil prices (DBO) (UCO). Crude oil prices stayed strong at more than $70 per barrel last week. Read Is $73 Possible for US Crude Oil Until Next Week? for the latest updates on crude oil prices.
According to the EIA’s (U.S. Energy Information Administration) latest Drilling Productivity Report, US crude oil production from the seven key shale plays (Anadarko, Appalachia, Bakken, Eagle Ford, Haynesville, Niobrara, and Permian) will rise 144 Mboepd (thousand barrels of oil equivalent per day) in June to ~7.2 MMboepd (million barrels of oil equivalent per day) compared to May.
12h - Asif
Overview Anthera Pharmaceuticals, Inc. is a biopharmaceutical company focused on advancing the development and commercialization of innovative medicines that benefit patients with unmet medical needs. The company currently have two compounds in development, Sollpura and blisibimod. The company licensed Sollpura from Eli Lilly & Co (“Eli Lilly”) in July 2014. Sollpura is a novel non-porcine investigational Pancreatic Enzyme Replacement Therapy (“PERT”) intended for the treatment of patients with Exocrine Pancreatic Insufficiency (“EPI”), often seen in patients with cystic fibrosis and other conditions. The company licensed blisibimod from Amgen, Inc. (“Amgen”) in December 2007. Blisibimod targets B-cell activating factor, or BAFF, which has been shown to be elevated in a variety of B-cell mediated autoimmune diseases, including Immunoglobulin A nephropathy, or IgA nephropathy. Sollpura The exocrine pancreas is responsible for synthesis and secretion of digestive en...
12h - Asif
Business Agenus is a clinical-stage immuno-oncology (“I-O”) company dedicated to becoming a leader in the discovery and development of innovative combination therapies and committed to bringing effective medicines to patients with cancer. The company's business is designed to drive success in I-O through speed, innovation, and effective combination therapies. Agenus has assembled fully integrated capabilities from novel target discovery, antibody generation, cell line development, and good manufacturing practice (“GMP”) manufacturing together with a comprehensive portfolio consisting of antibody-based therapeutics, adjuvants and cancer vaccine platforms. The company leverage its immune biology platforms to identify effective combination therapies for development and have developed productive partnerships to advance its innovation. The company believe the next generation of cancer treatment will build on clinically validated antibodies targeting CTLA-4 and PD-1 combined wi...
22h - Asif
Business The company started Square in February 2009 to enable businesses (sellers) to accept card payments, an important capability that was previously inaccessible to many businesses. However, sellers also need innovative solutions to thrive, and Square has since expanded to provide additional products and services to give these businesses access to the same tools as large businesses. This approach aligns with its purpose of economic empowerment, as everything the company do should give sellers accessible, affordable tools to grow their businesses and participate in the economy. Square is a cohesive commerce ecosystem that helps its sellers start, run, and grow their businesses. The company combine sophisticated software with affordable hardware to enable sellers to turn mobile and computing devices into powerful payment and point-of-sale solutions. Square has high seller acceptance rates and fast onboarding, while maintaining low risk and fraud losses as a result of its a...
as of ET